Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point?

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Vascular Biology

Background:

• Endothelial dysfunction is an early indicator of atherosclerotic cardiovascular disease.
• It is closely associated with both reversible (hypertension, hypercholesterolemia) and irreversible (age, family history) cardiovascular risk factors.
• The precise role of endothelial dysfunction as an independent risk factor versus an intermediate endpoint is debated.

Purpose of the Study:

• To explore the significance of endothelial dysfunction in cardiovascular disease.
• To evaluate its relevance as a therapeutic target.
• To clarify its relationship with established cardiovascular risk factors.

Main Methods:

• Review of existing literature on endothelial dysfunction and cardiovascular disease.
• Analysis of the association between endothelial dysfunction and cardiovascular risk factors.
• Discussion of therapeutic implications and research findings.

Main Results:

• Endothelial dysfunction is consistently observed in early stages of atherosclerosis.
• It correlates strongly with major cardiovascular risk factors.
• Evidence suggests it may be more accurately classified as an intermediate or surrogate endpoint rather than an independent risk factor.

Conclusions:

• Targeting conventional cardiovascular risk factors remains the primary therapeutic strategy.
• While not definitively an independent risk factor, improving endothelial dysfunction may provide additional benefits.
• Further research is needed to fully elucidate its role and therapeutic potential in cardiovascular disease management.